Middle East Healthcare Co (SAU:4009) Mohanram G-Score: 4 (As of Mar. 2026) — 100% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4009 Middle East Healthcare Co SAU:4009
79 GF Score
Price ﷼30.28
GF Value ﷼80.23
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Middle East Healthcare Co Mohanram G-Score?

Middle East Healthcare Co SAU:4009 +0.60% 79 Mohanram G-Score is 4 as of Mar. 2026, which is 100% above its 10-year median of 2.00. GuruFocus rates SAU:4009 with a GF Score™ of 79/100 and a GF Value™ of ﷼80.23 (Possible Value Trap). The stock has 5 warning signs investors should review.

Mohanram G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. Companies have higher G-score tends to generate higher return. According to his study, the best growth stocks that have a G-Score greater than 6 tend to beat the market, while those with a G-Score lower than 1 tend to have negative absolute returns.

Thus, the zones of discrimination were as such:

Good or high score = 6, 7, 8
Bad or low score = 0, 1

Middle East Healthcare Co has an G-score of 4.

The historical rank and industry rank for Middle East Healthcare Co's Mohanram G-Score or its related term are showing as below:

SAU:4009' s Mohanram G-Score Range Over the Past 10 Years
Min: 0   Med: 2   Max: 5
Current: 4

During the past 11 years, the highest Piotroski G-score of Middle East Healthcare Co was 5. The lowest was 0. And the median was 2.

Middle East Healthcare Co  (SAU:4009) Mohanram G-Score Explanation

Partha Mohanram is the John H. Watson Chair in Value Investing at Rotman and the Acting Vice-Dean of Research Strategy and Resources.

In 2000, he wrote a research paper called "Separating Winners from Losers Among Low Book-to-Market Stocks Using Financial Statement Analysis".

This paper tests whether a strategy based on financial statement analysis of low book-to-market (growth) stocks is successful in differentiating between winners and losers in terms of future stock performance. Based on the research, a strategy based on buying high G-score (6, 7 or 8) firms and shorting low G-score (0 or 1) firms consistently earns significant excess returns. Further, the results do not support a risk based explanation for the book-to-market effect as the strategy returns positive returns in all years, and firms that ex-ante appear less risky have better future returns.

To conclude, one can use a modified fundamental analysis strategy (G-score) to identify mispricing and earn substantial abnormal returns.


Middle East Healthcare Co Mohanram G-Score Related Terms


Middle East Healthcare Co Mohanram G-Score Historical Data

* Premium members only.

The historical data trend for Middle East Healthcare Co's Mohanram G-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Middle East Healthcare Co Mohanram G-Score Chart

Middle East Healthcare Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Mohanram G-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 3.00 2.00 3.00 3.00

Middle East Healthcare Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Mohanram G-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 3.00 4.00 3.00 4.00

SAU:4009 vs HCA, THC, DVA: Mohanram G-Score Comparison

For the Medical Care Facilities subindustry, Middle East Healthcare Co's Mohanram G-Score, along with its competitors' market caps and Mohanram G-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Middle East Healthcare Co Mohanram G-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Middle East Healthcare Co's Mohanram G-Score distribution charts can be found below:

* The bar in red indicates where Middle East Healthcare Co's Mohanram G-Score falls into.


SAU:4009
79GF Score
Middle East Healthcare Co SAU:4009
Mohanram G-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Middle East Healthcare Co Mohanram G-Score Calculation

The calculation of the Mohanram G-score consists of eight criteria. Assign one point for each criterion met, then add up all the points to get the G-Score.

Profitability

Question 1. Return on Assets (ROA)

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. It measures how well a company uses its asset to generate earnings.

Score 1 if ROA > ROA Industry Median, 0 otherwise.

Question 2. Cash ROA

Cash ROA equals to Cash Flow from Operations divided by average Total Assets. It measures how well a company uses its asset to generate cash.

Score 1 if Cash ROA > Cash ROA Industry Median, 0 otherwise.

Question 3. CFO and Net Income

Score 1 if CFO > Net Income, 0 otherwise.

Earnings Predictability

Question 4. Earnings Variability

Earnings Variability is measured as the variance of a firm's ROA in the past five years.

Score 1 if Earnings Variability < Earnings Variability Industry Median, 0 otherwise.

Question 5. Sales Growth Variability

Sales Growth Variability is measured as the 5-year variance in sales growth.

Score 1 if Sales Growth Variability < Sales Growth Variability Industry Median, 0 otherwise.

Accounting Conservatism

Question 6. Research & Development Intensity

Research & Development Intensity is calcualted by Research & Development divided by the beginning Total Assets.

Score 1 if Research & Development Intensity > Research & Development Intensity Industry Median, 0 otherwise.

Question 7. CAPEX Intensity

CAPEX Intensity is calcualted by Capital Expenditure divided by the beginning Total Assets.

Score 1 if CAPEX Intensity > CAPEX Intensity Industry Median, 0 otherwise.

Question 8. Advertising Expenditure Intensity

Advertising Expenditure Intensity is calcualted by Advertising Expenditure divided by the beginning Total Assets. Note that Advertising Expenditure is not reported as a seperate line item for many companies, thus Selling, General, & Admin. Expense is used in this calculation.

Score 1 if Advertising Expenditure Intensity > Advertising Expenditure Intensity Industry Median, 0 otherwise.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note that all the Industry Median used for comparison in his original research, are substituted with Sector Median due to the limitation of data within certain countries.

Good or high score = 6, 7, 8
Bad or low score = 0, 1

Middle East Healthcare Co has an G-score of 4.

Frequently Asked Questions Learn more about Mohanram G-Score →
What does a Mohanram G-Score of 4 mean?
Middle East Healthcare Co (SAU:4009) has a Mohanram G-Score of 4 as of Mar. 2026. G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. View historical data on Middle East Healthcare Co and its competitors. This is 100% above median its historical median of 2.00.
Is Middle East Healthcare Co's Mohanram G-Score too high?
Middle East Healthcare Co's current Mohanram G-Score of 4 is 100% above median its 10-year median of 2.00. Overall, Middle East Healthcare Co has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Middle East Healthcare Co's Mohanram G-Score compare to HCA and THC?
Middle East Healthcare Co's Mohanram G-Score of 4 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Mohanram G-Score for a Healthcare Providers & Services company?
A good Mohanram G-Score depends on the Healthcare Providers & Services industry context. However, Mohanram G-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Mohanram G-Score mean?
A high Mohanram G-Score can signal that a stock is expensive relative to its fundamentals. G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. View historical data on Middle East Healthcare Co and its competitors. Middle East Healthcare Co's current Mohanram G-Score is 4, which is 100% above median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Middle East Healthcare Co (SAU:4009) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼80.23, compared to a current price of ﷼30.28 — trading 62.3% below its estimated fair value. The current Mohanram G-Score is 4, which is 100% above median its 10-year median of 2.00. Middle East Healthcare Co's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Mohanram G-Score calculated?
Mohanram G-Score is calculated from a company's financial statements. For Middle East Healthcare Co (SAU:4009), the current Mohanram G-Score is 4 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Middle East Healthcare Co (SAU:4009) Overvalued in 2026?

Based on GuruFocus' analysis, Middle East Healthcare Co stock appears to be undervalued. The current stock price of ﷼30.28 is trading 62.3% below its estimated GF Value™ of ﷼80.23. GuruFocus considers Middle East Healthcare Co to be Possible Value Trap.

Key valuation signals for SAU:4009:

  • Mohanram G-Score: 4 (100% above median its 10-year median of 2.00)
  • GF Value™: ﷼80.23 vs. price of ﷼30.28 (62.3% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the SAU:4009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Middle East Healthcare Co Business Description

Address 4, Batterjee Road, P.O.Box 2550, Al-Zahra District, Jeddah, SAU, 21461
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company. The company's reportable segments are Inpatient Services, Outpatient Services, Pharmacy Sales and Others. The majority of revenue is derived from the Inpatient Services segment.
79GF Score

Get the complete analysis for SAU:4009

Mohanram G-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼30.28
Price
﷼80.23
GF Value